Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma
Sponsor: Sohag University
Summary
Endometrial cancer, the most common gynecologic cancer worldwide, is steadily increasing in developed countries.The early-stage forms of endometrial cancer are usually highly curable by surgical treatment alone, whereas advanced stages require adjuvant interdictions such as radiotherapy and chemotherapy. Platinum and anthracycline drugs have long been used as standard adjuvant chemotherapy drugs for advanced and recurrent endometrial carcinomas. In one study, the standard combination adjuvant treatment with AP was found to be more effective as an adjuvant therapy than whole abdominal irradiation
Key Details
Gender
FEMALE
Age Range
20 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-08-15
Completion Date
2025-08
Last Updated
2024-08-06
Healthy Volunteers
Yes
Conditions
Interventions
Paclitaxel/epirubcin/carboplatin
adjuvant treatment in endometrial carcinoma
Paclitaxel/carboplatin
Dose dense paclitaxel/carboplatin
Locations (1)
Sohag university Hospital
Sohag, Egypt